Related references
Note: Only part of the references are listed.Synthesis of ring opening of evodiamine derivatives and evaluation on their biological activity
Weihang Guo et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2022)
Neat1 promotes acute kidney injury to chronic kidney disease by facilitating tubular epithelial cells apoptosis via sequestering miR-129-5p
Tongtong Ma et al.
MOLECULAR THERAPY (2022)
WZY-321 triggers glioma cell apoptosis via XAF1 up-regulation caused by MTM-mediated miR-873 down-regulation
Guan Sun et al.
JOURNAL OF CANCER (2022)
Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway
Xiao Xu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Design, synthesis, and biological evaluation of 3′,4′,5′-trimethoxy evodiamine derivatives as potential antitumor agents
Yijiao Peng et al.
DRUG DEVELOPMENT RESEARCH (2021)
Mechanisms and Advances in Anti-Ovarian Cancer with Natural Plants Component
Jingyuan Wu et al.
MOLECULES (2021)
Lnc-NEAT1 induces cell apoptosis and inflammation but inhibits proliferation in a cellular model of hepatic ischemia/reperfusion injury
Liu Wang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2021)
Long non-coding RNA NEAT1 promotes human glioma tumor progression via miR-152-3p/CCT6A pathway
Bin Li et al.
NEUROSCIENCE LETTERS (2020)
LncRNAs in ovarian cancer
Jin-yan Wang et al.
CLINICA CHIMICA ACTA (2019)
Ovarian Cancer: An Integrated Review
Christine Stewart et al.
SEMINARS IN ONCOLOGY NURSING (2019)
miR-152 is involved in the proliferation and metastasis of ovarian cancer through repression of ERBB3
Lian-Wei Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
miRNAs and ovarian cancer: An overview
Bornali Deb et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
A comprehensive review of protein kinase inhibitors for cancer therapy
Radhamani Kannaiyan et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives
Xu Hu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Protein kinases that phosphorylate splicing factors: Roles in cancer development, progression and possible therapeutic options
Alicja Czubaty et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
Effect of evodiamine and berberine on the interaction between DNMTs and target microRNAs during malignant transformation of the colon by TGF-β1
Chao Huang et al.
ONCOLOGY REPORTS (2017)
Real-world evidence in the treatment of ovarian cancer
E. A. Eisenhauer
ANNALS OF ONCOLOGY (2017)
Acquired chemotherapy resistance in ovarian cancer
E. L. Christie et al.
ANNALS OF ONCOLOGY (2017)
Epidemiology of epithelial ovarian cancer
Penelope M. Webb et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2017)
Evodiamine from Evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells
Tze-Chien Chen et al.
PHYTOMEDICINE (2016)
HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer
Yiqing Chai et al.
CANCER MEDICINE (2016)
A novel serum microRNA panel to discriminate benign from malignant ovarian disease
Ream Langhe et al.
CANCER LETTERS (2015)
The history and future of targeting cyclin-dependent kinases in cancer therapy
Uzma Asghar et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine
Y. Xiang et al.
ONCOGENE (2014)
Pharmacological Actions of Multi-Target-Directed Evodiamine
Hui Yu et al.
MOLECULES (2013)